Ladenburg Thalmann Financial Services’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $1K | Sell |
294
-1,478
| -83% | -$5.03K | ﹤0.01% | 5283 |
|
|
2019
Q3 | $9K | Sell |
1,772
-27
| -2% | -$137 | ﹤0.01% | 4471 |
|
|
2019
Q2 | $10K | Sell |
1,799
-24
| -1% | -$133 | ﹤0.01% | 4464 |
|
|
2019
Q1 | $8K | Sell |
1,823
-5
| -0.3% | -$22 | ﹤0.01% | 4496 |
|
|
2018
Q4 | $8K | Sell |
1,828
-162
| -8% | -$709 | ﹤0.01% | 4422 |
|
|
2018
Q3 | $13K | Sell |
1,990
-440
| -18% | -$2.87K | ﹤0.01% | 4167 |
|
|
2018
Q2 | $19K | Hold |
2,430
| – | – | ﹤0.01% | 3875 |
|
|
2018
Q1 | $19K | Sell |
2,430
-216
| -8% | -$1.69K | ﹤0.01% | 3875 |
|
|
2017
Q4 | $17K | Buy |
2,646
+441
| +20% | +$2.83K | ﹤0.01% | 3904 |
|
|
2017
Q3 | $17K | Sell |
2,205
-221
| -9% | -$1.7K | ﹤0.01% | 3793 |
|
|
2017
Q2 | $17K | Sell |
2,426
-6,354
| -72% | -$44.5K | ﹤0.01% | 3720 |
|
|
2017
Q1 | $83K | Hold |
8,780
| – | – | ﹤0.01% | 2530 |
|
|
2016
Q4 | $76K | Buy |
8,780
+5,031
| +134% | +$43.5K | ﹤0.01% | 2532 |
|
|
2016
Q3 | $24K | Buy |
3,749
+930
| +33% | +$5.95K | ﹤0.01% | 3292 |
|
|
2016
Q2 | $12K | Buy |
2,819
+2,344
| +493% | +$9.98K | ﹤0.01% | 3685 |
|
|
2016
Q1 | $2K | Hold |
475
| – | – | ﹤0.01% | 4429 |
|
|
2015
Q4 | $3K | Hold |
475
| – | – | ﹤0.01% | 4279 |
|
|
2015
Q3 | $3K | Sell |
475
-700
| -60% | -$4.42K | ﹤0.01% | 4180 |
|
|
2015
Q2 | $8K | Buy |
1,175
+375
| +47% | +$2.55K | ﹤0.01% | 3844 |
|
|
2015
Q1 | $5K | Hold |
800
| – | – | ﹤0.01% | 4009 |
|
|
2014
Q4 | $6K | Buy |
800
+246
| +44% | +$1.85K | ﹤0.01% | 3682 |
|
|
2014
Q3 | $3K | Buy |
+554
| New | +$3K | ﹤0.01% | 3608 |
|